June 21, 2010 - Kowa Pharmaceuticals America and Lilly Announce U.S. Availability of Livalo

Read the full story

Providing Targeted Healthcare Solutions

Kowa Pharmaceuticals America, Inc. (KPA) is a specialty pharmaceutical company located in Montgomery, Alabama focused primarily in the area of cardiometabolic therapeutics. The company, started in 2001 as ProEthic Pharmaceuticals, Inc., was acquired by Kowa Company, Ltd. (KCL) a privately held multinational company headquartered in Nagoya, Japan in September of 2008. KPA focuses its efforts on the acquisition, development, licensing and marketing of pharmaceutical products.


Learn More >>